Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||1.66%||298.83||1.9%||$438.24m|
|GILD||Gilead Sciences, Inc.||0.65%||62.00||1.0%||$379.78m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.35%||622.15||2.6%||$351.29m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-12.15%||3.47||0.7%||$242.57m|
|GOVX||GeoVax Labs, Inc.||-0.35%||2.86||0.0%||$145.88m|
|CRSP||CRISPR Therapeutics AG||-7.69%||75.13||0.6%||$117.81m|
|PLRX||Pliant Therapeutics, Inc.||11.19%||21.16||0.0%||$108.38m|
|RYTM||Rhythm Pharmaceuticals, Inc.||7.19%||22.65||0.0%||$105.42m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.00%||95.70||4.2%||$98.26m|
Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.